Incara Pharmaceuticals Corp.

Incara Pharmaceuticals Corporation develops innovative therapies for diseases focusing on tissue protection, repair and regeneration. We are currently developing a portfolio of three potentially breakthrough treatments. Each of these productstargets a medical disorder for which there are no fully effective treatments. These three products are as follows: Liver precursor cell transplant, as a treatment for liver failure, Small molecule catalytic antioxidants, as a treatment for stroke and heart attack, OP2000, an ultra-low molecular weight heparin, being developed with Elan Corporation, pl.

Activity:

Product / Technology type(s) covered:

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: